Skip to main content
PALTC24 - AMDA Annual Conference Main banner
Purchase conference recordings
Purchase 2024 conference recordings
Evaluation

Innovation in PALTC

(SA24) To Test or Not to Test? Diagnostic Stewardship in PALTC

Saturday, March 9, 2024
4:30 PM - 5:30 PM CT
Room: 302
CMD Management Credit Recording
CME: (1) MOC: (1) CMD Management: (1) NP Pharmacology Hours ()
Disclosure(s):
Laurent Adler, MD CMD: No financial relationships to disclose.
Sing T. Palat, MD, CMD: No financial relationships to disclose.
To test or not to test? That is often the question. Diagnostic stewardship seeks to improve all steps of diagnostic testing in order to optimize patient outcomes. Whether a urinary tract infection (UTI), C difficile colitis, pulmonary embolism or bowel obstruction is suspected, the right diagnostic test for the right patient at the right time is essential for ensuring appropriate interventions. As newer diagnostic tests become available in PALTC settings, such as molecular testing in the diagnosis of UTI and soft tissue infections, medical directors and all clinical leaders within PALTC need to critically evaluate ordering, performing and reporting of diagnostic tests. This session will explore the steps of diagnostic stewardship that may be applied to PALTC settings to improve testing and patient outcomes.

Learning Objectives:

At the completion of this session, learners will be able to:
  • Identify the principles and impact of diagnostic stewardship.
  • Apply the principles of diagnostic stewardship to common testing scenarios for infectious diseases and other clinical conditions.
  • Recommend changes in the ordering, performing or reporting of diagnostic testing in PALTC
  • Engage in the selection of diagnostic testing options with PALTC interdisciplinary teams.